It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
We introduce a computational approach for the design of target-specific peptides. Our method integrates a Gated Recurrent Unit-based Variational Autoencoder with Rosetta FlexPepDock for peptide sequence generation and binding affinity assessment. Subsequently, molecular dynamics simulations are employed to narrow down the selection of peptides for experimental assays. We apply this computational strategy to design peptide inhibitors that specifically target β-catenin and NF-κB essential modulator. Among the twelve β-catenin inhibitors, six exhibit improved binding affinity compared to the parent peptide. Notably, the best C-terminal peptide binds β-catenin with an IC50 of 0.010 ± 0.06 μM, which is 15-fold better than the parent peptide. For NF-κB essential modulator, two of the four tested peptides display substantially enhanced binding compared to the parent peptide. Collectively, this study underscores the successful integration of deep learning and structure-based modeling and simulation for target specific peptide design.
Here the authors report a computational approach which integrates deep learning and structural modelling to design target-specific peptides. They apply this to β-catenin and NF-κB essential modulator, resulting in improved binding, highlighting the efficacy of this strategy.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Luo, Yichuan 4 ; Li, Xingcan 5 ; Pei, Dehua 3
; Kara, Levent Burak 6 ; Cheng, Xiaolin 7
1 The Ohio State University, College of Pharmacy, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943)
2 Carnegie Mellon University, Mechanical Engineering Department, Pittsburgh, USA (GRID:grid.147455.6) (ISNI:0000 0001 2097 0344); Carnegie Mellon University, Machine Learning Department, Pittsburgh, USA (GRID:grid.147455.6) (ISNI:0000 0001 2097 0344)
3 The Ohio State University, Department of Chemistry and Biochemistry, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943)
4 Carnegie Mellon University, Electrical and Computer Engineering Department, Pittsburgh, USA (GRID:grid.147455.6) (ISNI:0000 0001 2097 0344)
5 Affiliated Hospital and Medical School of Nantong University, Department of Radiology, Nantong, China (GRID:grid.260483.b) (ISNI:0000 0000 9530 8833)
6 Carnegie Mellon University, Mechanical Engineering Department, Pittsburgh, USA (GRID:grid.147455.6) (ISNI:0000 0001 2097 0344)
7 The Ohio State University, College of Pharmacy, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943); The Ohio State University, Translational Data Analytics Institute, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943)




